Tyra Biosciences, Inc.

NASDAQ:TYRA

14.25 (USD) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Revenue 00000
Cost of Revenue 0.3530.2960.140.0470.008
Gross Profit -0.353-0.296-0.14-0.047-0.008
Gross Profit Ratio 00000
Reseach & Development Expenses 62.51843.00820.6367.2031.79
General & Administrative Expenses 17.42715.9195.6522.0941.332
Selling & Marketing Expenses 00000
SG&A 17.42715.9195.6522.0941.332
Other Expenses 0-0.05-0.019-0.023-0.008
Operating Expenses 79.94558.92726.2889.2973.122
Operating Income -79.945-58.927-26.288-9.297-3.122
Operating Income Ratio 00000
Total Other Income Expenses Net 10.8113.602-0.006-0.039-0.943
Income Before Tax -69.134-55.325-26.294-9.336-4.065
Income Before Tax Ratio 00000
Income Tax Expense 0-3.602-0.153-0.022-0.007
Net Income -69.134-51.723-26.141-9.314-4.058
Net Income Ratio 00000
EPS -1.62-1.23-0.63-0.22-0.095
EPS Diluted -1.62-1.23-0.63-0.22-0.095
EBITDA -79.592-58.631-26.148-9.25-3.114
EBITDA Ratio 00000